Germany-based Cognis GmbH’s Care
Chemicals business unit has developed a new variant of Skintex® microencapsulation technology.
Developed in 2004 and targeted to apparel manufacturers, Skintex technology incorporates
microcapsules that contain active, naturally derived ingredients that are released to the skin at a
controlled rate over a fixed amount of time, imparting a range of benefits to consumers.
Chemicals business unit has developed a new variant of Skintex® microencapsulation technology.
Developed in 2004 and targeted to apparel manufacturers, Skintex technology incorporates
microcapsules that contain active, naturally derived ingredients that are released to the skin at a
controlled rate over a fixed amount of time, imparting a range of benefits to consumers.
The new Skintex Supercool variant contains high-tech microcapsules comprising such
ingredients as emollients, man-made coolants, menthol and myritol that, when applied to fabrics,
impart a cooling sensation as body heat and friction is generated.
August 21, 2007
